Key result
Treatment with reconstituted HDLMilano (MDCO-216) reversed pathological remodelling and cardiac dysfunction in a murine model of type 2 diabetic heart failure.
Why the study?
Heart failure risk is prominently increased in type 2 diabetes mellitus, prompting the evaluation of reconstituted HDLMilano administration on established heart failure in a murine model of diabetic cardiomyopathy.
Does reconstituted HDLMilano (MDCO-216) improve cardiac remodeling and function in a murine model of diabetic cardiomyopathy?
Does reconstituted HDLMilano (MDCO-216) improve cardiac remodeling and function in a murine model of diabetic cardiomyopathy?
Reconstituted HDLMilano (MDCO-216) effectively reverses heart failure and pathological remodeling in a murine model of diabetic cardiomyopathy.
Reconstituted HDL Milano reverses HF in this diabetic mouse model; leaves open translation to human diabetic cardiomyopathy.
The risk of heart failure (HF) is prominently increased in patients with type 2 diabetes mellitus. The objectives of this study were to establish a murine model of diabetic cardiomyopathy induced by feeding a high-sugar/high-fat (HSHF) diet and to evaluate the effect of reconstituted HDLMilano administration on established HF in this model. The HSHF diet was initiated at the age of 12 weeks and continued for 16 weeks. To investigate the effect of reconstituted HDLMilano on HF, eight intraperitoneal administrations of MDCO-216 (100 mg/kg protein concentration) or of an identical volume of control buffer were executed with a 48-h interval starting at the age of 28 weeks. The HSHF diet-induced obesity, hyperinsulinemia, and type 2 diabetes mellitus. Diabetic cardiomyopathy was present in HSHF diet mice as evidenced by cardiac hypertrophy, increased interstitial and perivascular fibrosis, and decreased myocardial capillary density. Pressure-volume loop analysis indicated the presence of both systolic and diastolic dysfunction and of decreased cardiac output in HSHF diet mice. Treatment with MDCO-216 reversed pathological remodelling and cardiac dysfunction and normalized wet lung weight, indicating effective treatment of HF. No effect of control buffer injection was observed. In conclusion, reconstituted HDLMilano reverses HF in type 2 diabetic mice.
No takes yet. Share an insight, caveat, or question.
Aboumsallem et al. (2019) studied Diabetic cardiomyopathy and heart failure. MDCO-216 (reconstituted HDLMilano) vs. Control buffer was evaluated on Cardiac hypertrophy, fibrosis, capillary density, and cardiac function. Treatment with reconstituted HDLMilano (MDCO-216) reversed pathological remodelling and cardiac dysfunction in a murine model of type 2 diabetic heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: